
The 2025 Revisions to the Pharmaceuticals and Medical Devices Act ― Impact on the Life Sciences and Healthcare Industry and Remaining Challenges ―
Pharmaceutical and Healthcare Seminar
Kensuke Suzuki, Masanori Tosu, Tomoharu Hagiwara
Nagashima Ohno & Tsunematsu Tokyo Office